EUVIMEDEUVIMED entdecken
Crossref

How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?

Kavitha Nallathambi, Amy B Cadwallader

AMA Journal of Ethics · 01.04.2024 · 26 (4) · E289-294

DOI: 10.1001/amajethics.2024.289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AMA Journal of Ethics, online erschienen am 01.04.2024. Verfasst von Kavitha Nallathambi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Former senior manager of global public policy at US Pharmacopeia. Hauptthemen laut MEDLINE: Excipients, Glycerol. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExcipientsGlycerolChildHumansPharmaceutical PreparationsDrug ContaminationCough

Substanzen

ExcipientsGlycerolPharmaceutical Preparations

Autor:innen und Institutionen

  • Former senior manager of global public policy at US Pharmacopeia.
  • Director of regulatory and public policy development at US Pharmacopeia.

Zitieren

APA

Nallathambi, K., & Cadwallader, A. B. (2024). How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?. AMA Journal of Ethics, 26(4), E289-294. https://doi.org/10.1001/amajethics.2024.289

Vancouver

Nallathambi K, Cadwallader AB. How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?. AMA Journal of Ethics. 2024;26(4):E289-294. doi:10.1001/amajethics.2024.289

BibTeX
@article{Nallathambi2024,
  author = {Nallathambi, Kavitha and Cadwallader, Amy B},
  title = {How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?},
  journal = {AMA Journal of Ethics},
  year = {2024},
  volume = {26},
  number = {4},
  pages = {E289--294},
  doi = {10.1001/amajethics.2024.289}
}
Kostenlos starten →